Interesting positive find:
By: sixersadvantcom
21 Nov 2007, 09:00 PM EST
Msg. 12657 of 12657
Jump to msg. #
Things are looking up for our little company. Director George Uveges purchased 20,000 shares on 11/19 & 11/20 for prices $1.10 to $1.14.
George has an impressive background. This is from the last 14-A filing.
"GEORGE UVEGES has served as a director of the Company since November 2005. Mr. Uveges is the founder and principal in the Tallwood Group, an angel investing firm that provides financial and management advisory services in addition to investment capital. Mr. Uveges has been a member of the adjunct faculty at Newbury College since 2006. From 2001 to 2004, Mr. Uveges served as the President and Chief Executive Officer of TranXenoGen, Inc., a development-stage, publicly-held biotech company focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products, including generics, a cancer treatment and antibodies. He was also a director of that company from 2001 to 2005. Prior to that, Mr. Uveges served as Chief Financial Officer at a number of companies and also practiced as a certified public accountant. Mr. Uveges is a member of the Board of Directors of Harvard Bioscience, Inc., a publicly held developer, manufacturer and marketer of products used in life science research, where he also serves on the audit committee. Mr. Uveges is also a member of the Board of Directors of Operation ABLE, a non-profit corporation. Mr. Uveges is the Chairman of the Company’s Nominating and Corporate Governance Committee, is a member of the Company’s Audit and Compensation Committees and is a “financial expert” on the Audit Committee."
Also, Robert Bruno exercised options for 39,750 shares and apparently held the shares.
Send stock manipulators to: enforcement@sec.gov-and to jail.
